PHARMACYTE BIOTECH, INC. Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount
PHARMACYTE BIOTECH, INC. (PMCB) reported Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount of -$996.65 thousand for the 12-month period ending 2024-04-30, per its 10-K filed 2024-08-13.
Discontinued › Expense Statement › Income Tax
us-gaap:IncomeTaxReconciliationNondeductibleExpense · last filed 2024-08-13
- PHARMACYTE BIOTECH, INC. effective income tax rate reconciliation, nondeductible expense, amount for fiscal 2024 was -$996.65K.
- PHARMACYTE BIOTECH, INC. effective income tax rate reconciliation, nondeductible expense, amount for fiscal 2023 was -$12.46K, a 160.77% decline from fiscal 2022.
- PHARMACYTE BIOTECH, INC. effective income tax rate reconciliation, nondeductible expense, amount for fiscal 2022 was $20.51K, a 73.79% decline from fiscal 2021.
- PHARMACYTE BIOTECH, INC. effective income tax rate reconciliation, nondeductible expense, amount for fiscal 2021 was $78.26K, a 68.56% decline from fiscal 2020.
| Period end | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount 12 month | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount 12 month as first filed |
|---|---|---|
| 2024-04-30 | -$996.65K 10-K · filed 2024-08-13 | |
| 2023-04-30 | -$12.46K 10-K · filed 2024-08-13 | |
| 2022-04-30 | $20.51K 10-K · filed 2023-07-31 | |
| 2021-04-30 | $78.26K 10-K · filed 2022-07-28 | |
| 2020-04-30 | $248.91K 10-K · filed 2021-08-10 | |
| 2019-04-30 | $170.03K 10-K · filed 2020-08-13 | |
| 2018-04-30 | $286.00K 10-K · filed 2019-08-13 | |
| 2017-04-30 | $213.96K 10-K · filed 2018-07-20 | |
| 2016-04-30 | $711.32K 10-K · filed 2017-07-27 | |
| 2015-04-30 | $1.43M 10-K · filed 2016-07-29 | $1.61M 10-K · filed 2015-07-29 |
| 2014-04-30 | $644.29K 10-K · filed 2016-07-29 | |
| 2013-04-30 | $109.30K 10-K/A · filed 2016-01-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |